Drusen proteome analysis: An approach to the etiology of age-related macular degeneration
Open accessThe DOI matches its Crossref record; 39 of the 39 references it cites were found in a registry or an index; 3 of the 17 sources its claims cite were checked for support.
Abstract
Drusen are extracellular deposits that accumulate below the retinal pigment epithelium on Bruch's membrane and are risk factors for developing age-related macular degeneration (AMD). The progression of AMD might be slowed or halted if the formation of drusen could be modulated. To work toward a molecular understanding of drusen formation, we have developed a method for isolating microgram quantities of drusen and Bruch's membrane for proteome analysis. Liquid chromatography tandem MS analyses of drusen preparations from 18 normal donors and five AMD donors identified 129 proteins. Immunocytochemical studies have thus far localized ≈16% of these proteins in drusen. Tissue metalloproteinase inhibitor 3, clusterin, vitronectin, and serum albumin were the most common proteins observed in normal donor drusen whereas crystallin was detected more frequently in AMD donor drusen. Up to 65% of the proteins identified were found in drusen from both AMD and normal donors. However, oxidative protein modifications were also observed, including apparent crosslinked species of tissue metalloproteinase inhibitor 3 and vitronectin, and carboxyethyl pyrrole protein adducts. Carboxyethyl pyrrole adducts are uniquely generated from the oxidation of docosahexaenoate-containing lipids. By Western analysis they were found to be more abundant in AMD than in normal Bruch's membrane and were found associated with drusen proteins. Carboxymethyl lysine, another oxidative modification, was also detected in drusen. These data strongly support the hypothesis that oxidative injury contributes to the pathogenesis of AMD and suggest that oxidative protein modifications may have a critical role in drusen formation.
Overview
CoChat Summary
TL;DR
This study developed a method to isolate microgram quantities of drusen and analyzed their proteome by LC MS/MS, identifying 129 proteins from normal and AMD donor eyes. It reports oxidative protein modifications, especially carboxyethyl pyrrole adducts, that are more abundant in AMD Bruch’s membrane, supporting a role for oxidative injury in AMD pathogenesis.
Key findings
- LC MS/MS of drusen preparations from 18 normal donors and five AMD donors identified 129 proteins: 107 from normal donors and 62 from AMD donors. About 38% (41/107) of normal-donor proteins were also found in AMD donors, and 65% (42/62) of AMD-donor proteins were found in normal donors; 21 of 62 AMD proteins (≈33%) were not observed in normal donor drusen.
- TIMP3, clusterin, vitronectin, and serum albumin were the most common proteins in normal donor drusen, detectable in up to 80% of tissues from the 18 normal donors and 60% of drusen preparations from the five AMD donors. Crystallin was detected more frequently in AMD donor drusen.
- Immunocytochemistry localized ≈16% (21/129) of identified proteins in drusen.
- Oxidative modifications were observed, including apparent crosslinked species of TIMP3 and vitronectin and carboxyethyl pyrrole (CEP) protein adducts. By Western analysis, CEP immunoreactivity was present in 9 of 11 AMD samples versus 2 of 11 age-matched controls (Fischer’s test, P = 0.004 single-sided); carboxymethyl lysine was also detected in drusen.
Methods
- Human donor eyes from 29 normal and 16 AMD donors, ages 56–98 years, were used. Drusen isolation and protein identification used 23 eyes (18 normal, five AMD); Western analyses used 22 eyes (11 normal, 11 AMD). Eyes were enucleated 1.5–7 h after death and frozen.
- Drusen were manually isolated from Bruch’s membrane, proteins were extracted, trypsin-digested, and analyzed by liquid chromatography tandem MS (LC MS/MS) with database searching. Immunocytochemistry and Western analysis were used to confirm drusen localization and detect oxidative modifications.
- For CEP Western analysis, Bruch’s membrane/RPE/choroid from AMD and age- and gender-matched normal donors was subjected to SDS/PAGE (≈20 µg protein per lane) and probed with anti-CEP antibodies.
Limitations
- The paper states that mass spectrometric analyses did not measure protein abundance; the number of proteins identified per drusen preparation varied from 0 to 39 and averaged 19. It also notes that some identified proteins may be soluble contaminants or, as with annexin II, localized to RPE tissue adhering to drusen, and that additional AMD donors are required to establish the significance of the crystallin observation.
- The paper states that whether any drusen protein is uniquely associated with AMD remains to be determined.
- Evident from the text: the AMD proteomic group was small (five donors), many isolated drusen were from far peripheral locations, and immunocytochemical confirmation covered only ≈16% of identified proteins.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
1 Valid · 1 Not valid · 8 Not checked · 29 Own results and interpretations
At least one cited source doesn’t support this claim or points to a different paper, and none confirmed it — see the verdicts below.
In the paper
“Among the nine identified immunopositive proteins were albumin and 𝛂 1-antitrypsin, both of which were detected in drusen by LC MS ∕ MS (Table 3) and immunocytochemistry (14).”
What the sources say
- Disputedcites [14] sourceExperimental — accuracy not yet measured
Our copy of Mullins et al. (2000) directly contradicts the attributed point: in the Immunohistochemistry section it states that 'Antibodies directed against human serum albumin and haptoglobin bound strongly to the choroidal stroma, but not to hard or soft drusen,' and Table 1 scores Albumin as negative for drusen (figure legend for panel J repeats that labeling was not generally observed with albumin antibodies). Alpha-1-antitrypsin is likewise not presented as an identified drusen component — the same section reports 'Weak and/or inconsistent drusen labeling of antibodies directed against the protease inhibitors alpha1-antitrypsin and alpha1-antichymotrypsin,' and Table 1 lists it as negative with only rare variable reactions. The proteins the paper does identify in all drusen phenotypes are amyloid P component, apolipoprotein E, immunoglobulin light chains, Factor X and complement C5/C5b-9 (Abstract; Immunohistochemistry), and the study contains no carboxyethylpyrrole/CEP-adduct work and no LC-MS/MS data. (LLM, conf=0.82)
Checked by a reasoning model — may be wrong.
plainSingle case- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Disputed
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“The multiple, higher mass electrophoretic components containing these proteins suggest the presence of covalent crosslinks, protein modifications that can be caused by reactive lipid and carbohydrate oxidation products (22, 23).”
What the sources say
- Partly supportedcites [22] Friguet, B., Stadtman, E. R. & Szweda, L. I. (1994) J. Biol. Chem. 269, 21639-21643. sourceExperimental — accuracy not yet measured
Friguet et al. (1994) directly support the lipid-oxidation half of what the paired citation is offered for: the Cross-linking of Glu-6-PDH by HNE section (Fig. 1) shows progressive appearance of higher-mass multimeric (dimeric, tetrameric) protein on SDS-gel filtration and SDS-gel electrophoresis after exposure to the lipid peroxidation product HNE, i.e. covalent cross-links, and the Discussion/Abstract state this explicitly. Our copy contains no passage attributing cross-linking to carbohydrate oxidation products (searched: carbohydrate/glycation cross-linking — only lipid peroxidation products HNE and malondialdehyde are discussed), so that half of the claim is not supported by this source; the cross-links shown are also formed in vitro on a heterologous bacterial model enzyme at 5 mM HNE, with the Discussion conceding basal in vivo HNE concentrations are ~3 orders of magnitude lower. The citing authors' own observation of higher-mass electrophoretic components containing TIMP-3 and vitronectin is not something this paper reports. (LLM, conf=0.70)
- Partly supportedcites [23] Elgawish, A., Glomb, M., Friedlander, M. & Monnier, V. M. R. (1996) J. Biol. Chem. 271, 12964-12971. sourceExperimental — accuracy not yet measured
Our copy of Elgawish et al. (1996) supports the carbohydrate-oxidation half of the attributed point: the Introduction (p.1) notes that 'metal-catalyzed glucose autoxidation may be more important than glycation for generation of fluorescent protein adducts and cross-links' and that deoxyosones/glyoxal and 'reactive ketoaldehydes might be responsible for collagen cross-linking', and the Discussion proposes an H2O2- and Amadori-product-driven covalent lysine-lysine cross-link. The lipid-oxidation half is not asserted by this paper: in the Discussion it appears only as an alternative model ('H2O2 ... could catalyze collagen cross-linking, e.g. through lipid peroxidation (44)'), which the authors immediately discount for their system ('Lipid peroxidation, however, is unlikely to be involved since many studies have shown that it is not preventable by catalase'). The paper also reports no electrophoretic high-mass protein components (its cross-linking readouts are tendon breaking time, linked fluorescence, CML, pentosidine), so it does not address the TIMP-3/vitronectin observation itself. (LLM, conf=0.72)
hedgedstates an associationSingle case- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Tissue metalloproteinase inhibitor 3, clusterin, vitronectin, and serum albumin were the most common proteins observed in normal donor drusen whereas crystallin was detected more frequently in AMD donor drusen.”
- Also stated in: § Results · hedged
“Tissue metalloproteinase inhibitor 3 (TIMP3), clusterin, vitronectin and serum albumin appear to be common drusen proteins, detectable in up to 80% of the tissues from the 18 normal donors”
plainn = 18- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Also stated in: § Results · hedged
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“By Western analysis they were found to be more abundant in AMD than in normal Bruch's membrane and were found associated with drusen proteins.”
- Also stated in: § Results · plain
“Western results (Fig. 3) revealed more frequent CEP immunoreactivity among the AMD samples than in the normal controls. Specifically, nine of the 11 AMD samples were immunopositive whereas only two of the 11 age-matched controls were CEP immunoreactive. Statistically these CEP immunoreactivity results are significantly different between AMD and normal donors (Fischer's test, P value = 0.004 single”
plainstates an associationn = 11- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Also stated in: § Results · plain
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Immunocytochemical studies have thus far localized ≈ 16% of these proteins in drusen.”
- Also stated in: § Discussion · plain
“To verify drusen localization, immunocytochemical studies are ongoing, and to date 21 of the identified proteins (16%) have been confirmed as drusen components in our laboratories and elsewhere.”
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Also stated in: § Discussion · plain
20 more claims
Create a free account to see all 39 claims and to verify the 14 references still open.
- Probably not a substantial claim. 9
- It may state two separate claims as one. 8
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Biochemical analysis of drusen has identified glycoconjugates and components found in atherosclerotic plaques including vitronectin, apolipoprotein B and E, alpha-crystallin, complement proteins, and lipids (32, 106, 115).”
From Unraveling a Multifactorial Late-Onset Disease: From Genetic Susceptibility to Disease Mechanisms for Age-Related Macular Degeneration (2009) · cites this paper as [32]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“In an AMD patient’s outer retina and plasma, there are more CEP-modified proteins when compared to age-matched controls (Crabb et al., 2002).”
From Retinal ultrastructure of murine models of dry age-related macular degeneration (AMD) (2010) · cites this paper as Crabb et al., 2002
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Serum albumin is one of the major proteins modified with CEP”
From Retinal ultrastructure of murine models of dry age-related macular degeneration (AMD) (2010) · cites this paper as Crabb et al., 2002
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Biochemical analysis of drusen have indeed resulted in identification of complement components and inflammatory modulators [2–8].”
From CFH Y402H confers similar risk of soft drusen and both forms of advanced AMD (2005) · cites this paper as [8]
The check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“immunize mice with CEP-modified mouse serum albumin, generating a strong immunologic response against endogenous CEP adducts in the outer retina”
From Retinal ultrastructure of murine models of dry age-related macular degeneration (AMD) (2010) · cites this paper as Crabb et al., 2002
Experimental — accuracy not yet measured
2 more claims about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
“65% (42 ∕ 62) of the proteins identified from AMD donor drusen were found in tissues from normal donors.”
Reported 65 · recomputed 67.741935
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ Discussion
“About 38% (41 ∕ 107) of the proteins identified from normal donor drusen were also found in drusen from AMD donors”
§ Discussion
“65% (42 ∕ 62) of the proteins identified from AMD donor drusen were found in tissues from normal donors”
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
“Twenty-one of the 62 proteins detected in drusen from AMD tissue ( ≈ 33%) were not observed in normal donor drusen (Table 3).”
Reported 21 · recomputed 22
Citations
Cites
A RAPID METHOD OF TOTAL LIPID EXTRACTION AND PURIFICATION
Bligh, E. G., & Dyer, W. J. (1959) · Canadian Journal of Biochemistry and Physiology · doi:10.1139/o59-099 · Cited by 54,751
The Role of Oxidative Stress in the Pathogenesis of Age-Related Macular Degeneration
Beatty, S., Koh, H.-H., Phil, M., Henson, D., & Boulton, M. (2000) · Survey of Ophthalmology · doi:10.1016/s0039-6257(00)00140-5 · Cited by 2,051
Allikmets, R., Singh, N., Sun, H., Shroyer, N. F., Hutchinson, A., Chidambaram, A., Gerrard, B., Baird, L., Stauffer, D., Peiffer, A., et al. (1997) · Nature Genetics · doi:10.1038/ng0397-236 · Cited by 1,435
Hageman, G. (2001) · Progress in Retinal and Eye Research · doi:10.1016/s1350-9462(01)00010-6 · Cited by 1,265
Chemistry and metabolism of lipids in the vertebrate retina
Fliesler, A. J., & Anderson, R. E. (1983) · Progress in Lipid Research · doi:10.1016/0163-7827(83)90004-8 · Cited by 1,052
Mullins, R. F., Russell, S. R., Anderson, D. H., & Hageman, G. S. (2000) · The FASEB Journal · doi:10.1096/fasebj.14.7.835 · Cited by 937
Ahmed, M. U., Thorpe, S. R., & Baynes, J. W. (1986) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)89188-3 · Cited by 864
Identification of the gene responsible for Best macular dystrophy
Petrukhin, K., Koisti, M. J., Bakall, B., Li, W., Xie, G., Marknell, T., Sandgren, O., Forsman, K., Holmgren, G., Andreasson, S., et al. (1998) · Nature Genetics · doi:10.1038/915 · Cited by 689
Positional cloning of the gene associated with X-linked juvenile retinoschisis
Sauer, C. G., Gehrig, A., Warneke-Wittstock, R., Marquardt, A., Ewing, C. C., Gibson, A., Lorenz, B., Jurklies, B., & Weber, B. H. F. (1997) · Nature Genetics · doi:10.1038/ng1097-164 · Cited by 497
Research works printed but not linked: 3
- Midena E., Deglii Angeli, C., Blarzino, M., Valenti, M. & Segato, T. (1997) Invest. Ophthalmol. Visual Sci.38,469-477.9040480
- Kamei M. & Hollyfield, J. E. (1999) Invest. Ophthalmol. Visual Sci.40,2367-2375.10476804
- Handa J. T., Verzijl, N., Matsunaga, H., Aotaki-Keen, A., Lutty, G. A., te Koppele, J. M., Miyata, T. & Hjelmeland, L. M. (1999) Invest. Ophthalmol. Visual Sci.40,775-779.10067983
Cited by
The Retinal Pigment Epithelium in Visual Function
Strauss, O. (2005) · Physiological Reviews · doi:10.1152/physrev.00021.2004 · Cited by 2,828
“However, a more detailed analysis of the protein composition of Drusen led to alternative theories of Drusen formation (128, 226, 519).”
BackgroundHageman, G. S., Anderson, D. H., Johnson, L. V., Hancox, L. S., Taiber, A. J., Hardisty, L. I., Hageman, J. L., Stockman, H. A., Borchardt, J. D., Gehrs, K. M., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0501536102 · Cited by 1,961
Complement regulators and inhibitory proteins
Zipfel, P. F., & Skerka, C. (2009) · Nature Reviews Immunology · doi:10.1038/nri2620 · Cited by 1,264
The AMD Genetics Clinical Study Group, Gold, B., Merriam, J. E., Zernant, J., Hancox, L. S., Taiber, A. J., Gehrs, K., Cramer, K., Neel, J., Bergeron, J., et al. (2006) · Nature Genetics · doi:10.1038/ng1750 · Cited by 1,075
Current concepts in the pathogenesis of age-related macular degeneration
Zarbin, M. A. (2004) · Archives of Ophthalmology · doi:10.1001/archopht.122.4.598 · Cited by 1,006
“As noted in the “Bruch Membrane Thickness” subsection, mutations in TIMP-3 cause Sorsby fundus dystrophy, which is associated accumulation of abnormal extracellular material in the Bruch membrane, patchy choroidal filling on fluorescein angiography, and CNVs.”
Influential
Metadata
- Authors
- Crabb, J. W., Miyagi, M., Gu, X., Shadrach, K., West, K. A., Sakaguchi, H., Kamei, M., Hasan, A., Yan, L., Rayborn, M. E., Salomon, R. G., & Hollyfield, J. G.
- Affiliations
- Cleveland Clinic (US)
- Venue
- Proceedings of the National Academy of Sciences
- Publisher
- National Academy of Sciences
- Published
- 2002-10-21
- Volume
- 99
- Issue
- 23
- Pages
- 14682-14687
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- PMC
- PMC137479
- OpenAlex
- W2136501493
- Semantic Scholar
- 56777252bd03c9f9e59663891e03c8a458996b5f
- Cited by
- 1,208
- References
- 39
- Citations by year
- 2026: 30 · 2025: 40 · 2024: 35 · 2023: 39 · 2022: 52 · 2021: 56 · 2020: 49 · 2019: 34 · 2018: 65 · 2017: 62 · 2016: 44 · 2015: 56 · 2014: 73 · 2013: 57 · 2012: 69
- FWCI
- 38.28
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Proceedings of the National Academy of Sciences (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Foundation Fighting Blindness
- Cleveland Clinic
- Cleveland Clinic Foundation
- National Institutes of Health (5r01ey002362-23, EY06603)
- National Eye Institute (R56EY014240, EY014239, EY06603, EY 014240, F32EY006603, R01EY006603, R01EY014239, EY 02362, R01EY014240)
- National Institute of General Medical Sciences (R01GM021249, GM 21249)
- Topics
- Health Sciences › Medicine › Ophthalmology › Retinal Diseases and Treatments
- Health Sciences › Medicine › Radiology, Nuclear Medicine and Imaging › Retinal Imaging and Analysis
- Physical Sciences › Chemistry › Spectroscopy › Advanced Proteomics Techniques and Applications
- Keywords
- drusen, age-related macular degeneration, Bruch's membrane, retinal pigment epithelium, protein oxidation, carboxymethyllysine, vitronectin, clusterin, serum albumin, crystallins, drusen formation, AMD pathogenesis
- MeSH terms
- Aged, Aged, 80 and over, Aging, Choroid, Enzymes, Eye, Eye Proteins, Humans, Macular Degeneration, Middle Aged, Reference Values, Retina, Optic Disk Drusen, Proteomics
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
The claim verdicts this report counts are experimental: their accuracy is not yet measured.
A language model drew the claims from the paper on 2026-10-05, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-05 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (qwen3.8-omni-flash).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Drusen proteome analysis: An approach to the etiology of age-related macular degeneration. https://app.cochat.ai/papers/10.1073/pnas.222551899
- The paper
- Crabb, J. W., Miyagi, M., Gu, X., Shadrach, K., West, K. A., Sakaguchi, H., Kamei, M., Hasan, A., Yan, L., Rayborn, M. E., Salomon, R. G., & Hollyfield, J. G. (2002). Drusen proteome analysis: An approach to the etiology of age-related macular degeneration. Proceedings of the National Academy of Sciences. https://doi.org/10.1073/pnas.222551899
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.